YN14-H
YN14-H is a potent mutant KRASG12C PROTAC degrader. The DC50 values of YN14-H in NCI-H358 and MIA PaCa-2 cells are 28.9 nM and 18.1 nM, respectively, with corresponding IC50 values of 42 nM and 21 nM. YN14-H degrades KRASG12C in a ubiquitin-proteasome system-dependent manner, thereby significantly inducing apoptosis and inhibiting cell migration. YN14-H can be used for targeting tumors with KRASG12C mutations (such as non-small cell lung cancer, pancreatic cancer, etc.).
(Pink: KRas G12C ligand (HY-173252); Blue: VHL ligand (HY-125905); Black: linker).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C65H78F3N11O8S
- Masse moléculaire:1230.44
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform PROTACs
More
Activité biologique
Description
IC50 & Target
[1]|
KRAS(G12C) 28.9 nM (DC50, NCI-H358) |
KRAS(G12C) 18.1 nM (DC50, MIA PaCa-2) |
In Vitro
YN14-H (500 ns) promotes the formation of more stable interactions in the KRASG12C-VHL ternary complex, which is evidenced by a binding free energy of -158.12 kJ/mol and the presence of 10 stable hydrogen-bond interactions between the two proteins[1].
YN14-H (0.01 nM-1 μM) induces the formation of the KRASG12C-VHL ternary complex with high affinity, with a dissociation constant Kd of 18.8 nM[1].
YN14-H (0-5 μM) potently induces the KRASG12C-VHL protein-protein interaction, which is validated by a strong relative AlphaScreen luminescent signal[1].
YN14-H (1 μM; 8 h) most effectively promotes the interaction between endogenous KRASG12C and VHL in NCI-H358 cells[1].
YN14-H (1 nM-10 μM; 72 h) potently degrades KRASG12C protein in NCI-H358 and MIA PaCa-2 cells, with a DC50 of 28.9 nmol/L in the former and 18.1 nmol/L in the latter, and achieves a maximal degradation rate of over 95% in both cell types[1].
YN14-H (0-10 μM; 72 h) potently inhibits the proliferation of NCI-H358 (IC50 = 0.042 μmol/L) and MIA PaCa-2 (IC50 = 0.021 μmol/L) cells, whereas it exhibits no cytotoxicity in non-KRASG12C cells even at concentrations up to 10 μmol/L[1].
YN14-H (0.01-1 μM; 48 h) potently inhibits the levels of phosphorylated AKT and ERK in a concentration-dependent manner in NCI-H358 and MIA PaCa-2 cells[1].
YN14-H (100 nM; 12 h) potently inhibits the migratory capacity of NCI-H358 and MIA PaCa-2 cells[1].
YN14-H (100 nM; 48 h) induces apoptosis in 35.19% of NCI-H358 cells and 55.19% of MIA PaCa-2 cells, and its efficacy is superior to that of other tested degraders[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:NCI-H358 and MIA PaCa-2
-
Concentration:1 nM, 3.3 nM, 10 nM, 33 nM, 100 nM, 330 nM, 1 μM, 3.3 μM, 10 μM
-
Incubation Time:72 h
-
Result:Significantly degraded the KRASG12C protein in a concentration-dependent manner, with a maximum degradation rate exceeding 98%.
-
Cell Line:NCI-H358 and MIA PaCa-2
-
Concentration:0.01, 0.1, 1 μM
-
Incubation Time:48 h
-
Result:Significantly inhibited the phosphorylation of downstream signaling molecules AKT and ERK in a concentration-dependent manner.
-
Cell Line:NCI-H358 and MIA PaCa-2
-
Concentration:100 nM
-
Incubation Time:48 h
-
Result:Significantly induced apoptosis in both tumor cell lines, demonstrating superior pro-apoptotic ability compared to other tested compounds.
-
Cell Line:NCI-H358 and MIA PaCa-2
-
Concentration:100 nM
-
Incubation Time:12 h
-
Result:Significantly inhibited the migration and wound closure of tumor cells.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude (male, xenograft model with 5 x 106 NCI-H358 cells)[1]
-
Dosage:10 mg/kg; 30 mg/kg
-
Administration:i.p.; once daily; 20 days
-
Result:Achieved a tumor growth inhibition (TGI) rate of 88.68% at 10 mg/kg at 14 days post-treatment.
Induced marked tumor regression with a TGI of 95.4% at 30 mg/kg at 14 days post-treatment.
Reduced tumor volume to approximately 500 mm3 in the 10 mg/kg group by day 20.
Caused complete tumor regression in the 30 mg/kg group by day 20.
Reduced KRASG12C protein levels in tumor tissue to a greater extent than YN14 at matching doses.
Reduced the percentage of Ki67-positive and CD31-positive tumor cells with greater potency than YN14 at matching doses.
Increased the percentage of cleaved caspase 3-positive tumor cells with greater potency than YN14 at matching doses.
Showed no obvious body weight loss or toxic signs during treatment.
Chemical Information
-
Masse moléculaire 1230.44
-
Formule C65H78F3N11O8S
-
SMILES
O=C([C@H]1N(C([C@@H](NC(C2(F)CC2)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC3=CC=C(C4=C(C)N=CS4)C=C3OCCCN5CCC(COC6=CC=CC(F)=C6C7=C(F)C=C(C(N8[C@@H](C)CN(C(C=C)=O)CC8)=N9)C(N(C%10=C(C)C=CN=C%10C(C)C)C9=O)=N7)CC5
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Scratch/Wound-Healing Migration Assay
The scratch/wound-healing migration assay measures collective migration of adherent cells into an experimentally created cell-free gap in a confluent monolayer. The readout is generated by imaging the gap immediately after scratching and at later time points, then quantifying reduction in wound area, wound width, or percentage closure as cells move into the denuded region. Gap closure reflects cell migration but may also include cell proliferation, so interpretation should distinguish migration-focused conditions from proliferation-driven closure when possible, such as by using short assay windows, serum-controlled conditions, cell counting, or proliferation controls reported in published protocols.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Neural Crest/Neuronal Cell Migration Explant Assay
Neural crest (NC) and neuronal cell migration explant assays are in vitro systems in which neural tube-derived tissues are cultured to allow premigratory or newly emigrated neural crest cells to undergo epithelial-to-mesenchymal transition (EMT), migrate away from the explant, and form a measurable radial outgrowth that reflects migratory capacity and environmental responsiveness. These assays typically quantify migration by measuring the expansion of cell outgrowth from neural tube or neural plate border explants over time, often comparing early and later timepoints to derive a migration index such as a radius ratio, which reflects net cell dispersal from the explant core. Neural tube explant cultures preserve key aspects of neural crest behavior, including EMT, migration, and early differentiation, making them suitable for assessing intrinsic migratory ability and extrinsic cue dependence. However, studies emphasize that migratory outgrowth from neural tube explants may include non-n
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Chemotaxis Gradient Chamber Assay 1
The chemotaxis gradient chamber assay is based on the principle of observing directional cell migration in response to a stable, linear or quasi-linear concentration gradient of a chemoattractant formed between two fluid reservoirs separated by a narrow observation chamber. Cells placed within the chamber respond to the gradient by polarized movement toward higher chemoattractant concentrations, allowing quantification of chemotactic behavior in real time under microscopy. The classic Zigmond chamber design enables simultaneous visualization of gradient formation and individual cell trajectories, making it suitable for studying leukocyte chemotaxis and other motile cell types in vitro.
-
Under-Agarose Cell Migration Assay
The under-agarose cell migration assay is a classical in vitro chemotaxis method designed to evaluate directed cell movement through a semi-solid agarose matrix toward soluble chemoattractant gradients, enabling visualization and quantification of leukocyte or motile cell migration in a confined 2D-like environment. In this system, cells and chemoattractants are placed in separate wells cut into an agarose gel, allowing diffusion-driven gradient formation that guides directional migration, which is typically assessed by measuring migration distance, cell morphology changes, and accumulation toward the chemoattractant source. This assay has been widely used to study neutrophil and leukocyte chemotaxis as a simple alternative to filter-based migration systems and allows direct microscopic observation of migrating cells under near-physiological confinement conditions.
-
Transwell/Boyden Chamber Migration Assay
The Transwell/Boyden chamber migration assay measures cell movement through a porous membrane separating an upper and lower chamber, usually after a chemoattractant gradient is established by placing cells in the upper chamber and chemoattractant-containing medium in the lower chamber. The readout is generated by quantifying cells that traverse the membrane and appear on the lower membrane surface or in the lower chamber, depending on whether the cell type is adherent or non-adherent. This assay reflects chemotactic or haptotactic migration rather than matrix invasion unless an extracellular-matrix barrier is added to the membrane.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
3D Collagen/Hydrogel Matrix Migration Assay
The 3D collagen/hydrogel matrix migration assay is based on embedding cells within or on top of a fibrillar collagen type I-rich three-dimensional matrix to model in vivo-like extracellular matrix (ECM) architecture, enabling analysis of cell migration through a physically and biochemically relevant scaffold. In contrast to 2D migration systems, cells in 3D matrices interact with fibrillar collagen networks, requiring coordinated adhesion remodeling and proteolytic or non-proteolytic deformation mechanisms to move through confined spaces, thereby providing a more physiologically relevant readout of invasive and migratory behavior in tissue-like environments. Cell movement in 3D collagen matrices is typically quantified by tracking single-cell trajectories, invasion depth, or matrix penetration over time, reflecting combined effects of cytoskeletal dynamics, cell-ECM adhesion turnover, and ECM remodeling. These systems are widely used to study tumor cell invasion and stromal cell motili
-
Cell-Exclusion Zone Migration Assay
The Cell-Exclusion Zone (CEZ) migration assay is an in vitro 2D cell migration method in which a defined cell-free area is created using removable physical barriers such as silicone stoppers, allowing cells to be seeded around the barrier and subsequently migrate into the cleared zone after barrier removal. This approach enables quantification of collective cell migration by monitoring repopulation of the initially cell-free region over time using microscopy-based imaging. Compared with scratch-based wound healing assays, barrier-based exclusion methods are designed to avoid mechanical damage to the extracellular matrix and reduce injury-induced effects on boundary cells, thereby improving interpretability of migration behavior in vitro. The assay readout is typically the progressive reduction in the cell-free area or the number of cells invading the exclusion zone, reflecting coordinated cell motility relevant to physiological processes such as wound healing, epithelial repair, and ca
-
Chemotaxis Gradient Chamber Assay 2
Chemotaxis gradient chamber assays measure directional cell migration in response to a soluble chemical gradient by imaging cells as they move across a defined observation region; the readout is generated from time-lapse cell trajectories, displacement toward the gradient, forward migration index, trajectory plots, rose/polar plots, and statistical tests of non-random directionality. The Dunn chamber is a direct-viewing glass chamber in which cells migrate across a bridge between control and chemoattractant wells, allowing observation of cells in a linear concentration gradient; related direct-viewing formats include the Insall chamber, which supports defined unidirectional gradients and high numerical-aperture microscopy, and the μ-Slide Chemotaxis chamber, which supports long-term live-cell imaging and gradient characterization with fluorescent dye.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)